Loading...
•
Sep 30, 2023
Pulmonx Q3 2023 Earnings Report
Pulmonx achieved record worldwide revenue driven by strength in the U.S.
Key Takeaways
Pulmonx reported record third-quarter results with worldwide revenue of $17.7 million, a 31% increase year-over-year. U.S. revenue grew by 41% to $11.8 million. The company is increasing its full-year revenue expectation to $67 million to $68 million.
Achieved record worldwide revenue of $17.7 million, a 31% increase year-over-year.
Delivered record U.S. revenue of $11.8 million, representing 41% year-over-year growth.
Realized a gross margin of 74%.
Added 15 new U.S. treatment centers for Zephyr Valves.
Revenue by Geographic Location
Forward Guidance
Pulmonx is increasing its expectation for revenue in 2023 to now range from $67 million to $68 million and expects gross margin for the full year 2023 to be approximately 74%.
Positive Outlook
- Revenue in 2023 to range from $67 million to $68 million.
- Represents approximately 25% to 27% growth over the Company's fiscal year 2022 revenue.
- Gross margin for the full year 2023 to be approximately 74%.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...